41results about How to "Inhibition of production" patented technology

The invention discloses an eye cream, the main point of which is the technical proposal, including the following materials: water, polydimethylsiloxane / vinyl polydimethylsiloxane crosslinked polymer, cyclopentasiloxane Oxane, Vinyl Dimethicone / Methicone Silsesquioxane Crosspolymer, Dimethicone PEG‑10 / 15 Crosspolymer, Dimethicone Silicone, Glycerin, CI47005, Phenyl Trimethicone, Sodium Chloride, Phenoxyethanol, Methylparaben, Propylparaben, Rhododendron Extract, Oat Kernel Extract, Centella Asiatica Extract medicine, lavender oil. The present invention is different from the traditional formula, adding a variety of plant extracts, supplementing sufficient nutrients and water to the eyes, restoring the elasticity of the eye skin, promoting the metabolism of eye cells, and at the same time solving dark circles, eye bags, eye wrinkles, etc. Problem Action, one eye cream that addresses multiple eye concerns at an affordable price.

An application of the quercetol-3-0-beta-D-glucoside in preparing the medicines for treating cerebral anoxia and ischemia, and thrombosis is disclosed. Said quercetol-3- 0-beta-D-glucoside is prepared from rutine by semi-synthesis method with high output.

The invention discloses a class of 2,5-dihydroxyterephthalamide compounds (I) and pharmaceutically acceptable salts thereof, their preparation methods, pharmaceutical compositions and preparations for treating and / or preventing nervous system-related diseases Use in pharmaceuticals, including but not limited to vascular dementia, Alzheimer's disease, Parkinson's disease, Huntington's disease, HIV-related dementia, multiple sclerosis, amyotrophic lateral sclerosis, neuropathic pain, Glaucoma, ischemic stroke, hemorrhagic stroke, and neurological damage caused by traumatic brain injury;

Disclosed is a Tat PTD-Endostatin recombinant protein, which is a fusion protein comprising a protein transduction domain of human immunodeficiency virus transactivation transduction protein Tat and human endostatin. The amino acid sequence of the protein transduction domain of the human immunodeficiency virus transactivation transduction protein Tat is represented by SEQ ID NO.1, and the amino acid sequence of the human endostatin is represented by SEQ ID NO.2. The protein of the present invention maintains the function that the endostatin can inhibit angiogenesis, has advantages of high transduction efficiency, easy blood-brain barrier crossing, and easy blood-ocular barrier crossing, overcomes the limitation of the poor membrane spanning effect of the endostatin, can play the angiogenesis inhibition effect better, and can be used for treatment of various diseases caused by angiogenesis, comprising ocular vascular proliferative diseases and various tumors, such as diabetes induced retinopathy, non-small cell lung cancer, and the like.

The invention discloses a class of hydroxyflurbiprofen Mannich base compound (I) and its pharmaceutically acceptable salt, its preparation method, pharmaceutical composition and preparation of medicines for treating and / or preventing neurodegenerative related diseases Including but not limited to vascular dementia, Alzheimer's disease, Parkinson's disease, Huntington's disease, HIV-related dementia, multiple sclerosis, progressive lateral sclerosis, neuropathic pain, glaucoma, etc. Neurodegenerative diseases;.

The invention discloses a dehydrogenation zaluzanin C derivative and a preparation method and application thereof. The dehydrogenation zaluzanin C derivative is a compound of a structure as indicated in formula I or medically acceptable salt of the compound, tautomer, stereisomer or a precursor compound. The dehydrogenation zaluzanin C derivative is obtained by conducting chemical modification on dehydrogenation zaluzanin C. It is indicated by experiments that the dehydrogenation zaluzanin C derivative has a remarkable anti-inflammatory function, especially for acute peritonitis, is expected to be developed as an anti-inflammatory drug, especially as the anti-inflammatory drug for treating acute peritonitis and has medicinal value.

The invention discloses a class of benzylamino flurbiprofen amide compound (I) and its pharmaceutically acceptable salt, its preparation method, pharmaceutical composition and preparation of medicines for treating and / or preventing nervous system related diseases. Uses, including but not limited to vascular dementia, Alzheimer's disease, Parkinson's disease, Huntington's disease, HIV-related dementia, multiple sclerosis, amyotrophic lateral sclerosis, neuropathic pain, glaucoma, Hemorrhagic stroke, hemorrhagic stroke, and nerve damage caused by traumatic brain injury and other diseases;